2157 — Lepu Biopharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for Lepu Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	205	669	490	465	959
Net Total Accounts Receivable
Net Total Receivables	0.073	25.3	55.2	81.8	132
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	314	813	677	646	1,142
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	978	1,039	1,087	1,051	1,027
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	2,082	2,529	2,384	2,281	3,100
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	549	844	900	1,044	1,162
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,245	1,628	1,487	1,578	1,713
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	837	901	897	703	1,386
Total Liabilities & Shareholders' Equity	2,082	2,529	2,384	2,281	3,100
Total Common Shares Outstanding